Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy
Mohamed Abouelleil, Nachiket Deshpande, Rushna Ali
Abstract
Epilepsy is a neurological disorder that affects more than 70 million people globally. A considerable proportion of epilepsy is resistant to anti-epileptic drugs (AED). For patients with drug-resistant epilepsy (DRE), who are not eligible for resective or ablative surgery, neuromodulation has been a palliative option. Since the approval of vagus nerve stimulation (VNS) in 1997, expansion to include other modalities, such as deep brain stimulation (DBS) and responsive neurostimulation (RNS), has led to improved seizure control in this population. In this article, we discuss the current updates and emerging trends on neuromodulation for epilepsy.
Topics & Concepts
NeuromodulationVagus nerve stimulationEpilepsyDeep brain stimulationNeurostimulationDrug Resistant EpilepsyMedicineEpilepsy surgeryPopulationAnesthesiaStimulationPsychiatryVagus nerveDiseaseInternal medicineParkinson's diseaseEnvironmental healthVagus Nerve Stimulation ResearchNeurological disorders and treatmentsNeuroscience and Neural Engineering